Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046)

Summary

This study will evaluate the pharmacokinetics of ridaforolimus including the area under the concentration-time curve (AUC\[0-infinity\]) and maximum concentration (Cmax) after administration of a single dose of ridaforolimus in patients with moderate hepatic insufficiency and healthy matched control subjects.

Timeline

Start

2010-01

Primary completion

2010-04

Completion

2010-04

Drugs

Indications